Skip to main content
Article thumbnail
Location of Repository

A potent 2′-O-methylated RNA-based microRNA inhibitor with unique secondary structures

By Takeshi Haraguchi, Haruo Nakano, Takanobu Tagawa, Tokimitsu Ohki, Yoshihito Ueno, Tetsuo Yoshida and Hideo Iba


MicroRNAs (miRNAs) are involved in various biological processes and human diseases. The development of strong low-molecular weight inhibitors of specific miRNAs is thus expected to be useful in providing tools for basic research or in generating promising new therapeutic drugs. We have previously described the development of ‘Tough Decoy (TuD) RNA’ molecules, which achieve the long-term suppression of specific miRNA activity in mammalian cells when expressed from a lentivirus vector. In our current study, we describe new synthetic miRNA inhibitors, designated as S-TuD (Synthetic TuD), which are composed of two fully 2′-O-methylated RNA strands. Each of these strands includes a miRNA-binding site. Following the hybridization of paired strands, the resultant S-TuD forms a secondary structure with two stems, which resembles the corresponding TuD RNA molecule. By analyzing the effects of S-TuD against miR-21, miR-200c, miR-16 and miR-106b, we have elucidated the critical design features of S-TuD molecules that will provide optimum inhibitory effects following transfection into human cell lines. We further show that the inhibitory effects of a single transfection of S-TuD-miR200c are quite long-lasting (>7 days) and induce partial EMT, the full establishment of which requires 11 days when using a lentivirus vector that expresses TuD-miR200c continuously

Topics: Methods Online
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). A cellular microRNA mediates antiviral defense in human cells.
  2. (2009). CENTROIDFOLD: a web server for RNA secondary structure prediction.
  3. (2007). Double-stranded regions are essential design components of potent inhibitors of RISC function.
  4. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
  5. (2006). Improved targeting of miRNA with antisense oligonucleotides.
  6. (2007). Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.
  7. (2006). LNA-modified oligonucleotides mediate specific inhibition of microRNA function.
  8. (2005). MicroRNA expression profiles classify human cancers.
  9. (2011). MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy.
  10. (2007). MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.
  11. (2011). MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation.
  12. (2011). MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
  13. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function.
  14. (2004). MicroRNAs: small RNAs with a big role in gene regulation.
  15. (2007). miR-181a is an intrinsic modulator of T cell sensitivity and selection.
  16. (2011). miR-301a as an NF-kB activator in pancreatic cancer cells.
  17. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.
  18. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
  19. (2005). Principles of microRNA-target recognition.
  20. (2008). promotes cellular outgrowths.
  21. (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs.
  22. (2004). Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing.
  23. (2005). Silencing of microRNAs in vivo with ‘antagomirs’.
  24. (2004). Structural requirements for pre-microRNA binding and nuclear export by Exportin 5.
  25. (2004). The functions of animal microRNAs.
  26. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
  27. (2009). Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.